Related Experiment Video
Updated: Sep 18, 2026

Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays
Published on: November 12, 2012
The Gini coefficient as a surrogate for the regulability or homeostasis of metabolite concentrations: focus on
Douglas B Kell1,2, Warwick B Dunn3, Catherine L Winder3
1Centre for Metabolomics Research, Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown St, Liverpool, L69 7ZB, UK. dbk@liv.ac.uk.
Abstract:
The Gini coefficient is a simple non-parametric statistic that reflects the degree of variation of a property between individuals or samples, taking a value between zero and one. We here develop the idea that if the metabolism of a metabolite is tightly regulated it should have a low Gini coefficient whereas if for instance it is exogenous and present only in a subset of samples (e.g. from individuals that have ingested the substance and/or metabolised it to various degrees) the Gini coefficient will be much greater. Analysis of published datasets shows this to be true, allowing one to suggest that the Gini coefficient might assist in assessing both regulability and the origin of a particular metabolite. Plasma amino acid levels are especially tightly regulated (some have a Gini coefficient less than 0.1, a value lower than that for any transcript), while exogenous drugs and their metabolites have the highest Gini coefficients (some over 0.8). Vitamins are essential and exogenous (but regulated) and have intermediate values (ca. 0.2-0.4). Ergothioneine is a valuable nutraceutical that is not synthesised by humans and it is also of some interest to assess the variation in its distribution. A number of studies find it normally to have a Gini coefficient in the range 0.3-0.4, and with lower levels of the Gini coefficient (as in a pilot study summarised here) suggesting a relatively weak exogenous exposure. Overall, we consider that the Gini coefficient provides a convenient means of describing the extent to which a metabolite concentration varies over a metabolomic dataset, and hence the extent to which it may be regulated.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Quantitative Aspects of Drug-Receptor Interaction
Regulation of Metabolism
Turnover Number and Catalytic Efficiency
Chymotrypsin is a pancreatic enzyme that breaks down proteins during digestion. The...
Drug Concentrations: Measurements
Plasma —...
Measurement of Bioavailability: Pharmacokinetic Methods

